kata pengantar
Post on 14-Dec-2015
219 Views
Preview:
DESCRIPTION
TRANSCRIPT
KATA PENGANTAR
Segala puji dan syukur kehadirat Tuhan Yang Maha Esa yang telah
melimpahkan rahmat dan petunjuk-Nya sehingga penulis dapat menyusun dan
menyelesaikan materi mengenai “NONSTEROIDAL ANTIINFLAMMATORY
DRUGS (NSAID)”.
Penulis menyadari bahwa penyusunan Laporan Kasus ini jauh dari
kesempurnaan, maka dari itu kritik dan saran yang sifatnya membangun sangat
penulis harapkan demi kesempurnaan laporan ini.
Mataram, 4 Juli 2015
Penulis
DAFTAR ISI
Kata Pengantar ................................................................................................. i
Daftar isi .......................................................................................................... ii
BAB I. Pendahuluan ........................................................................................ 1
1.1. Latar Belakang .......................................................................................... 1
BAB II. Landasan Teori .................................................................................. 3
2.1. Nonsteroidal antiinflammatory drugs (NSAID) ....................................... 3
2.1.1. Pengertian .............................................................................................. 3
2.1.2. Patologi Nyeri ........................................................................................ 3
2.1.3. Mekanisme Kerja NSAID ...................................................................... 4
2.1.4. Farmakodinamik .................................................................................... 5
2.1.5. Efek Samping NSAID ........................................................................... 6
2.1.6. Penggunaan NSAID ............................................................................... 6
2.1.7. Klasifikasi NSID .................................................................................... 8
2.1.8. Obat Anti Inflamasi Non Steroid ........................................................... 14
2.2. Ketorolac ................................................................................................... 20
2.2.1. Indikasi .................................................................................................. 20
2.2.2. Farmakodinamik .................................................................................... 20
2.2.3. Farmakokinetik ...................................................................................... 21
2.2.4. Dosis ...................................................................................................... 21
2.2.5. Efek Samping ......................................................................................... 22
2.2.6. Kontraindikasi ........................................................................................ 23
BAB III. Laporan Kasus .................................................................................. 24
3.1. Identitas Pasien ......................................................................................... 24
3.2. Pre Operatif ............................................................................................... 24
BAB IV. Pembahasan ...................................................................................... 28
BAB V. Penutup .............................................................................................. 29
5.1. Simpulan ................................................................................................... 29
Daftar Pustaka .................................................................................................. 30
top related